Low Molecular Weight Heparin: Clinical Trials

4 trials for Low Molecular Weight Heparin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Terminated 1

Follow Low Molecular Weight Heparin: new trials by email Literature Review of Low Molecular Weight Heparin trials Research Report on Low Molecular Weight Heparin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Aspirin, Low-molecular-weight heparin - Venous Thromboembolism, Postpartum Period
Phase 3RecruitingUniversity of Calgary88052026-06-042026-07-27
Effect of Low Molecular Weight Heparin in Freeze-thaw Embryo Transfer Cycles in Women With Recurrent Implantation Failure
Low Molecular Weight Heparine - Low Molecular Weight Heparin, Recurrent Implantation Failure
CompletedThe Second Hospital of Shandong University3922021-01-012025-08-12
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
s-LMWH, LMWH, Argatroban - Gynecologic Neoplasms, Venous Thromboembolism
Phase 3CompletedHuazhong University of Science and Technology3152016-01-012019-05-14
Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial
Parnaparin Sodium - Infertility, Low Molecular Weight Heparin
Phase 3TerminatedIstituto Clinico Humanitas2712011-07-012016-12-14

Narrower conditions

Venous Thromboembolism (2)  ·  Genital Neoplasms, Female (1)  ·  Infertility (1)  ·  Postpartum Hemorrhage (1)  ·  Pre-Eclampsia (1)  ·  Pulmonary Embolism (1)  ·  Thrombophilia (1)  ·  Venous Thrombosis (1)

Broader conditions

Urogenital Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Embolism and Thrombosis (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Thromboembolism (2)  ·  Vascular Diseases (2)  ·  Embolism (1)  ·  Female Urogenital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhage (1)  ·  Hypertension, Pregnancy-Induced (1)  ·  Lung Diseases (1)

Interventions

Heparin, Low-Molecular-Weight (2)  ·  Aspirin (1)  ·  Dalteparin (1)  ·  Enoxaparin (1)  ·  Fluxum (1)  ·  Nadroparin (1)  ·  Tinzaparin (1)  ·  argatroban (1)  ·  parnaparin (1)

Sponsors

Huazhong University of Science and Technology (1)  ·  Istituto Clinico Humanitas (1)  ·  The Second Hospital of Shandong University (1)  ·  University of Calgary (1)

Countries

China (2)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Poland (1)

Top investigators

Ding Ma, M.D. (1)  ·  Leslie Skeith, MD (1)  ·  Marc Rodger, MD (1)